Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery

Colloids and Surfaces B: Biointerfaces

Volumn 122, Issue , 2014, Pages 38-45

  Morales, Javier O ^a   Huang, Siyuan ^b   Williams, Robert O ^b   McConville, Jason T ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Buccal delivery; Insulin coated nanoparticles; Permeation enhancement; Protein and peptide delivery

Indexed keywords

NANOPARTICLES; PEPTIDES;

BUCCAL ADMINISTRATION; BUCCAL DELIVERIES; CATIONIC POLYMETHACRYLATES; COPRECIPITATION METHOD; FABRICATION PROCESS; HYDROXYPROPYL METHYLCELLULOSE; PEPTIDE DELIVERY; PERMEATION ENHANCEMENT; COATED NANOPARTICLES;

INSULIN;

HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; NANOPARTICLE; POLYMETHACRYLIC ACID DERIVATIVE; DRUG CARRIER;

ARTICLE; BIOFILM; CHEEK MUCOSA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG TRANSPORT; HUMAN; IN VITRO STUDY; INSULIN RELEASE; MATERIAL COATING; MEMBRANE TRANSPORT; MORPHOLOGY; MUCOADHESION; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; ZETA POTENTIAL; BIOLOGICAL MODEL; CHEEK; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; BUCCAL DRUG ADMINISTRATION; DRUG STABILITY; HUMAN TISSUE; NANOFABRICATION;

CHEEK; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; HUMANS; HYPROMELLOSE DERIVATIVES; INSULIN; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; NANOPARTICLES;

EID: 84904358029     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.05.025     Document Type: Article

References (48)

1. Tan M.L., Choong P.F.M., Dass C.R. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 2010, 31:184-193. 10.1016/j.peptides.2009.10.002.
2. Frokjaer S., Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 2005, 4:298-306. 10.1038/nrd1695.
3. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 1999, 185:129-188. 10.1016/S0378-5173(99)00152-0.
4. Peyrot M., Rubin R.R., Kruger D.F., Travis L.B. Correlates of insulin injection omission. Diabetes Care 2010, 33:240-245. 10.2337/dc09-1348.
5. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int. J. Obes. Relat. Metab. Disord. 2002, 26:S18-S24. 10.1038/sj.ijo.0802173.
6. Polonsky W.H., Fisher L., Guzman S., Villa-Caballero L., Edelman S.V. Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care 2005, 28:2543-2545. 10.2337/diacare.28.10.2543.
7. Ghilzai N.M.K. New developments in insulin delivery. Drug Dev. Ind. Pharm. 2003, 29:253. 10.1081/DDC-120018199.
8. Khafagy E.-S., Morishita M., Onuki Y., Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev. 2007, 59:1521-1546. 10.1016/j.addr.2007.08.019.
9. Heinemann L., Jacques Y. Oral insulin and buccal insulin: a critical reappraisal. J. Diabetes Sci. Tech. 2009, 3:568-584.
10. Leader B., Baca Q.J., Golan D.E. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov. 2008, 7:21-39. 10.1038/nrd2399.
11. Jitendra P.K., Bansal S., Banik A. Noninvasive routes of proteins and peptides drug delivery. Indian J. Pharm. Sci. 2011, 73:367.
12. Shojaei A.H. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1998, 1:15-30. doi:10942969.
13. Morales J.O., Ross A.C., McConville J.T. Protein-coated nanoparticles embedded in films as delivery platforms. J. Pharm. Pharmacol. 2013, 65:827-838. 10.1111/jphp.12046.
14. Singh R., Singh S., Lillard J.W. Past, present, and future technologies for oral delivery of therapeutic proteins. J. Pharm. Sci. 2008, 97:2497-2523. 10.1002/jps.21183.
15. Perumal V.A., Govender T., Lutchman D., Mackraj I. Investigating a new approach to film casting for enhanced drug content uniformity in polymeric films. Drug Dev. Ind. Pharm. 2008, 34:1036-1047. doi:902381180.
16. Cui F., He C., He M., Tang C., Yin L., Qian F., et al. Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin. J. Biomed. Mater. Res. A 2009, 89A:1063-1071. 10.1002/jbm.a.32071.
17. Giovino C., Ayensu I., Tetteh J., Boateng J.S. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Int. J. Pharm. 2012, 428:143-151. 10.1016/j.ijpharm.2012.02.035.
18. Morales J.O., Joks G.M., Lamprecht A., Ross A.C., McConville J.T. A design of experiments to optimize a new manufacturing process for high activity protein-containing submicron particles. Drug Dev. Ind. Pharm. 2013, 39:1793-1801. 10.3109/03639045.2012.737332.
19. Kreiner M., Fuglevand G., Moore B.D., Parker M.-C. DNA-coated microcrystals. Chem. Commun. 2005, 2675-2676. 10.1039/b501045d.
20. Partridge J., Moore B.D., Parker M.C. Stabilization of proteins in the dry state without sugars. AAPS J. 2005, 7:2989.
21. Partridge J., Halling P.J., Moore B.D. Practical route to high activity enzyme preparations for synthesis in organic media. Chem. Commun. 1998, 84:841-842. 10.1039/A800408K.
22. Nikolic K., Murugesan M., Forshaw M., Cunningham D., Martinez-Albertos J.-L., Moore B.D. Self-assembly of nanoparticles on the surface of ionic crystals: structural properties. Surf. Sci. 2007, 601:2730-2734. 10.1016/j.susc.2006.12.034.
23. Morales J.O., Su R., McConville J.T. The influence of recrystallized caffeine on water-swellable polymethacrylate mucoadhesive buccal films. AAPS PharmSciTech 2013, 14:475-484.
24. Weatherell J.A., Robinson C., Rathbone M.J. The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity. Oral Mucosal Drug Delivery 1996, 157-189. Marcel Dekker Inc., New York. M.J. Rathbone (Ed.).
25. Higuchi T. Mechanism of sustained-action medication. The theoretical analysis of rate of solids drugs dispersed in solid matrices. J. Pharm. Sci. 1963, 52:1145-1149. doi:14088963.
26. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35. 10.1016/0378-5173(83)90064-9.
27. Costa P., Sousa Lobo J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Biopharm. 2001, 13:123-133. 10.1016/S0928-0987(01)00095-1.
28. Giovino C., Ayensu I., Tetteh J., Boateng J.S. An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Colloids Surf. B: Biointerfaces 2013, 112:9-15. 10.1016/j.colsurfb.2013.07.019.
29. Zhang Y., Huo M., Zhou J., Zou A., Li W., Yao C., et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010, 12:263-271. 10.1208/s12248-010-9185-1.
30. Murdan S., Somavarapu S., Ross A.C., Alpar H.O., Parker M.C. Immobilisation of vaccines onto micro-crystals for enhanced thermal stability. Int. J. Pharm. 2005, 296:117-121. 10.1016/j.ijpharm.2005.02.022.
31. Kreiner M., Parker M.C., Moore B.D. Enzyme-coated micro-crystals: a 1-step method for high activity biocatalyst preparation. Chem. Commun. 2001, 1096-1097. 10.1039/b100722j.
32. Scharnagl C., Reif M., Friedrich J. Stability of proteins: temperature, pressure and the role of the solvent. Biochim. Biophys. Acta (BBA) - Proteins Proteomics 2005, 1749:187-213. 10.1016/j.bbapap.2005.03.002.
33. Mortazavian E., Dorkoosh F.A., Rafiee-Tehrani M. Design, characterization and ex vivo evaluation of chitosan film integrating of insulin nanoparticles composed of thiolated chitosan derivative for buccal delivery of insulin. Drug Dev. Ind. Pharm. 2014, (in press). 10.3109/03639045.2014.886590.
34. Di Colo G., Zambito Y., Zaino C. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J. Pharm. Sci. 2008, 97:1652-1680. 10.1002/jps.21043.
35. Shegokar R., Muller R.H. Nanocrystals industrially feasible multifunctional formulation technology for poorly soluble actives. Int. J. Pharm. 2010, 399:129-139. 10.1016/j.ijpharm.2010.07.044.
36. Peppas N.A., Sahlin J.J. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 1996, 17:1553-1561. 10.1016/0142-9612(95)00307-X.
37. Smart J.D. The role of water movement and polymer hydration in mucoadhesion. Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Development 1999, 11-23. Marcel Dekker Inc., New York. E. Mathiowitz, D.E. Chickering, C.M. Lehr (Eds.).
38. Nafee N.A., Ismail F.A., Boraie N.A., Mortada L.M. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int. J. Pharm. 2003, 264:1-14. 10.1016/S0378-5173(03)00371-5.
39. Wong C.F., Yuen K.H., Peh K.K. An in-vitro method for buccal adhesion studies: importance of instrument variables. Int. J. Pharm. 1999, 180:47-57. 10.1016/S0378-5173(98)00402-5.
40. Asane G.S., Nirmal S.A., Rasal K.B., Naik A.A., Mahadik M.S., Rao Y.M. Polymers for mucoadhesive drug delivery system: a current status. Drug Dev. Ind. Pharm. 2008, 34:1246-1266. 10.1080/03639040802026012.
41. Wong C.F., Yuen K.H., Peh K.K. Formulation and evaluation of controlled release Eudragit buccal patches. Int. J. Pharm. 1999, 178:11-22. 10.1016/S0378-5173(98)00342-1.
42. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Deliv. Rev. 1993, 11:37-57. 10.1016/0169-409X(93)90026-Z.
43. Yadev N.P., Murdoch C., Saville S.P., Thornhill M.H. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis. Microb. Pathog. 2011, 50:278-285. 10.1016/j.micpath.2010.11.009.
44. Sohi H., Ahuja A., Ahmad F.J., Khar R.K. Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev. Ind. Pharm. 2010, 36:254-282.
45. Caramella C., Ferrari F., Bonferoni M., Rossi S., Sandri G. Chitosan and its derivatives as drug penetration enhancers. J. Drug Deliv. Sci. Technol. 2010, 20:5-13.
46. Squier C.A. Zinc iodide-osmium staining of membrane-coating granules in keratinized and non-keratinized mammalian oral epithelium. Arch. Oral Biol. 1982, 27:377-382.
47. Wertz P.W., Swartzendruber D.C., Squier C.A. Regional variation in the structure and permeability of oral mucosa and skin. Adv. Drug Deliv. Rev. 1993, 12:1-12. 10.1016/0169-409X(93)90037-5.
48. Senel S., Kremer M.J., Kas S., Wertz P.W., Incal A.A.H., Squier C.A. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 2000, 21:2067-2071. 10.1016/S0142-9612(00)00134-4.